Article: Center for Inherited Disease Research Adds Affymetrix Platform for Large-Scale Genotyping Services.

First Project to Focus on Identifying Genetic Causes of Type 2 Diabetes

SANTA CLARA, Calif. -- Affymetrix Inc. (Nasdaq:AFFX) today announced that the Center for Inherited Disease Research (CIDR) has adopted its Genome-Wide Human SNP Array 6.0 for large-scale genotyping and copy number projects. CIDR is making Affymetrix-based genotyping available to supporting members of the National Institutes of Health (NIH). The first study to take advantage of this new CIDR offering is a NIDDK-funded project to identify the genetic causes of type 2 diabetes in African-Americans.

Donald W. Bowden, Ph.D. is director of the Wake Forest University School of Medicine ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!